Volume 31, Number 10—October 2025
EIN Letter
Emerging Sexual Transmission of Trichophyton mentagrophytes Genotype VII Infections, United States
Priyanka Anand, Laura A.S. Quilter, Jessica Penney, Philip M. Polgreen, Susan E. Beekmann, and Jeremy A.W. Gold
Table 2
Awareness of TMVII infection, diagnosis, laboratory testing, and treatment among 117 polled member clinicians of the Emerging Infections Network, United States, 2025*
| Survey question | Yes | No | Not sure or not answered |
|---|---|---|---|
| In the past year, I have seen or consulted on a patient with a dermatophyte infection that was suspicious for TMVII infection |
5 (4) |
105 (90) |
7 (6) |
| In the past year, I have seen or managed a patient with a laboratory-confirmed TMVII infection |
1 (1) |
110 (94) |
6 (5) |
| I know when to suspect TMVII infection in clinical practice |
42 (36) |
42 (36) |
33 (28) |
| If I saw a patient with potential TMVII infection, I would be able to obtain laboratory testing to determine the species |
33 (28) |
41 (35) |
43 (37) |
| I know how to treat TMVII infection |
27 (23) |
53 (45) |
37 (32) |
| I know how to counsel patients with TMVII infection about preventing spread | 34 (29) | 45 (38) | 38 (33) |
*Values are no. (%) respondents. TMVII, Trichophyton mentagrophytes genotype VII.
Page created: September 04, 2025
Page updated: September 25, 2025
Page reviewed: September 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.